Streetbeat News

UPH

UpHealth Inc

https://www.gigcapital2.com/

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

uphealth is built by forward-thinking industry experts bringing together a comprehensive platform to patients seeking medical care at any location.

Open

0.29

Mkt cap

5.3M

Volume

349K

High

0.30

P/E Ratio

-0.07

52-wk high

3.19

Low

0.25

Div yield

N/A

52-wk low

0.25

UpHealth, Inc. (NYSE: UPH) has appointed Jay Jennings as Acting CEO, replacing Martin Beck who resigned on July 10, 2024. Lisa Fluxman has been promoted to President of TTC Healthcare, and Jeremy Livianu remains Chief Legal Officer and Secretary.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 8:16 pm

The New York Stock Exchange (NYSE) has announced that it will start delisting proceedings against UpHealth (UPH). This action is due to non-compliance with the exchange's listing standards. The specific reasons for non-compliance were not detailed in the news provided.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 9:58 pm

In Monday's after-market session, several healthcare stocks experienced significant movements. SenesTech (SNES) saw a 42.0% increase, while Centessa Pharmaceuticals (CNTA) dropped by 10.6%. Other notable gainers include TC BioPharm (TCBP), Heart Test Laboratories (HSCS), UpHealth (UPH), AcelRx Pharmaceuticals (ACRX), and Sientra (SIEN). On the losing side, Redhill Biopharma (RDHL), OneMedNet (ONMD), Tharimmune (THAR), Envoy Medical (COCH), and Leap Therapeutics (LPTX) saw declines in their stock prices.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 9:31 pm

Health care stocks experienced significant movement in Monday's intraday session. Redhill Biopharma (RDHL) led the gainers with a 207.0% increase, while Harpoon Therapeutics (HARP) led the losers with a 25.1% decrease. Other notable movers included Biodexa Pharmaceuticals (BDRX), Tharimmune (THAR), Lexaria Bioscience (LEXX), and Mira Pharmaceuticals (MIRA) on the gainers' side, and Telesis Bio (TBIO), Altamira Therapeutics (CYTO), Universe Pharmaceuticals (UPC), Kazia Therapeutics (KZIA), and UpHealth (UPH) among the losers.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 5:30 pm

Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) shares increased by approximately 14% in pre-market trading following the announcement of its expansion into the Middle East market with the FF 91 2.0 Futurist aiFalcon, set to start deliveries in 2024. Other stocks experienced significant movement in pre-market trading, with FLJ Group Limited (NASDAQ:FLJ) and iRobot Corporation (NASDAQ:IRBT) among the notable gainers, while Impel Pharmaceuticals Inc. (NASDAQ:IMPL) and Aethlon Medical, Inc. (NASDAQ:AEMD) were among the losers.

Portfolio Pulse from Lisa Levin

November 24, 2023 | 12:59 pm

In Thursday's pre-market session, several healthcare stocks experienced significant movements. Heart Test Laboratories, NeuroOne Medical Tech, PaxMedica, Blue Water Biotech, OpGen, and Avinger saw their stocks rise, with increases ranging from 10.63% to 22.4%. On the other hand, Alterity Therapeutics, UpHealth, First Wave BioPharma, SILO Pharma, TRACON Pharma, and Altamira Therapeutics faced declines between 10.3% and 19.8%. Market caps for these companies vary, with the smallest at $2.6 million and the largest at $34.8 million.

Portfolio Pulse from Benzinga Insights

November 23, 2023 | 1:05 pm

During Wednesday's intraday session, several healthcare stocks experienced significant movements. PaxMedica (PXMD) saw a 33.6% increase, while Impel Pharmaceuticals (IMPL) rose by 32.68%. BioVie (BIVI) went up by 29.03%, Seelos Therapeutics (SEEL) by 22.61%, Heart Test Laboratories (HSCS) by 22.38%, and Agape ATP (ATPC) by 20.8%. On the downside, Entrada Therapeutics (TRDA) dropped by 30.2%, Alterity Therapeutics (ATHE) by 29.63%, Mira Pharmaceuticals (MIRA) by 23.98%, Alaunos Therapeutics (TCRT) by 21.67%, Inspire Veterinary (IVP) by 20.25%, and UpHealth (UPH) by 17.91%.

Portfolio Pulse from Benzinga Insights

November 22, 2023 | 5:31 pm

In Wednesday's pre-market session, several healthcare stocks experienced significant movements. Heart Test Laboratories, PaxMedica, NeuroOne Medical Tech, Apollomics, TC BioPharm, and Curis saw their stocks rise by 23.9%, 23.24%, 14.68%, 14.18%, 13.99%, and 12.32% respectively. Conversely, UpHealth, Alterity Therapeutics, Nexalin Technology, SILO Pharma, Acutus Medical, and TRACON Pharma faced declines of 20.2%, 15.97%, 15.52%, 11.96%, 10.44%, and 10.05% respectively.

Portfolio Pulse from Benzinga Insights

November 22, 2023 | 1:06 pm

In Tuesday's after-market session, several healthcare stocks experienced significant movements. Lexaria Bioscience (LEXX) led the gainers with a 19.0% increase, while Ainos (AIMD) saw the largest decline among the losers, dropping 11.0%. Other notable movers included Personalis (PSNL), Atreca (BCEL), Moleculin Biotech (MBRX), and Exagen (XGN) with gains, and Altamira Therapeutics (CYTO), SILO Pharma (SILO), Eiger BioPharmaceuticals (EIGR), UpHealth (UPH), and TRACON Pharma (TCON) with losses.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 9:31 pm

UpHealth (UPH) resumed trading on the NYSE on November 21, 2023, after providing disclosures in filings on November 20, 2023. The resumption follows a period of halted trading due to undisclosed reasons requiring the company to make regulatory filings.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 3:33 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.